the next concern would be to decrease or eliminate the symptoms that accompany the disease. The general life outlook for people with this disease has improved greatly over the years, with the mortality rate for patients with generalized myasthenia 30 percent, 31 percent showing deterioration or remaining unchanged, and only 29 percent having an improvement in their condition before 1958. Now with proper treatment, the mortality rate is essentially zero, although most patients must take immunosuppressive medication for the rest of their life. Management of myasthenia gravis varies according to the severity of the disease, the age of the patient, and the type of myasthenia the patient has. “About 10 percent of the diseases victims die. For those who survive the first three years, there is a chance for stabilization ad even some degree of recovery”(Howard). The main ways for treating myasthenia gravis include the use of cholinergic or anticholinestrase therapy that interfere with the activity of the enzyme acetylcholinesterase, immunosuppression therapy, removal of thethymus. In removing the Thethymus or performing a thethymus. The goal is to induce remission or improve reduction in immunosuppressice medication. The doctors whom perform this procedure really don’t know why it helps but it does so they will do it in order to help out someone who has this disease. But it is believed that the “thymectomy produces benefits in myasthenia gravis is still uncertain. In general, acetylcholine receptor-antibody levels fall after thymectomy, although there are conflicting reports. On theoretical grounds, there are several possible mechanisms. First, removal of the thymus may eliminate a source of continued antigenic stimulation. If the thymic myoid cells are the source of autoantigen then their removal might allow the immune response to subside. Second, thymectomy may remove a reservoir of B cells that are secreting acetylc...
